Increased stromal infiltrating lymphocytes are associated with the risk of disease progression in mesenchymal circulating tumor cell-positive primary breast cancer patients. In Onkológia. ISSN 1336-8176. Bratislava : SOLEN, 2021, 2021, roč. 16, č. 1, s. 71.